Lab Rats series: Cracking vaccines, biosecurity and personalized cancer with PopVax
Launched in 2021 in the thick of the covid pandemic, the Hyderabad-based startup has an ambitious pipeline of first-in-class vaccines and drugs that it hopes to accelerate to clinics in the next two years.
Mint asks for a subscription to read the full story. If you have one, sign in on their site.
0 comments